<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39603742</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2173-5107</ISSN><JournalIssue CitedMedium="Internet"><Volume>66 Suppl 2</Volume><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Radiologia</Title><ISOAbbreviation>Radiologia (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Ways of analysing extracellular gadolinium enhancement.</ArticleTitle><Pagination><StartPage>S65</StartPage><EndPage>S74</EndPage><MedlinePgn>S65-S74</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rxeng.2024.11.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2173-5107(24)00137-X</ELocationID><Abstract><AbstractText>The use of extracellular gadolinium-based contrast agents provides valuable information in magnetic resonance studies, thus increasing diagnostic confidence. These contrast agents make it easier to detect and define injuries, and narrow down the differential diagnosis. They are indicated for several different reasons, both for diagnostic purposes and for evaluating the response to treatment. Morphological analysis can assess the type of uptake, the qualitative and semiquantitative study of the signal intensity vs time curves in multiphase sequences, and the quantitative analysis of the uptake with T1 or T2* perfusion studies associated with pharmacokinetic models. Multiphase dynamic studies with 3D sequences contain valuable information that is not exploited by a simple visual analysis of 2D images. To take advantage of this information and the imaging biomarkers provided, computational analysis should be used. To this end, the future role of artificial intelligence is increasingly evident.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Espa&#xf1;a, S.L.U.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Casillas Mel&#xe9;ndez</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Diagn&#xf3;stico por Imagen, Consorcio Hospitalario Provincial de Castell&#xf3;n, Castell&#xf3;n, Spain. Electronic address: casillasmel@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Radiologia (Engl Ed)</MedlineTA><NlmUniqueID>101770876</NlmUniqueID><ISSNLinking>2173-5107</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>AU0V1LM3JT</RegistryNumber><NameOfSubstance UI="D005682">Gadolinium</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="Y">Contrast Media</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005682" MajorTopicYN="Y">Gadolinium</DescriptorName><QualifierName UI="Q000493" MajorTopicYN="N">pharmacokinetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008279" MajorTopicYN="Y">Magnetic Resonance Imaging</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005110" MajorTopicYN="N">Extracellular Space</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Contrast media</Keyword><Keyword MajorTopicYN="N">Image interpretation</Keyword><Keyword MajorTopicYN="N">Imagen de perfusi&#xf3;n</Keyword><Keyword MajorTopicYN="N">Inteligencia artificial</Keyword><Keyword MajorTopicYN="N">Interpretaci&#xf3;n de imagen</Keyword><Keyword MajorTopicYN="N">Medio de contraste</Keyword><Keyword MajorTopicYN="N">Multiparametric magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Perfusion imaging</Keyword><Keyword MajorTopicYN="N">Radiomics</Keyword><Keyword MajorTopicYN="N">Radi&#xf3;mica</Keyword><Keyword MajorTopicYN="N">Resonancia magn&#xe9;tica muliparam&#xe9;trica</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>0</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>20</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39603742</ArticleId><ArticleId IdType="doi">10.1016/j.rxeng.2024.11.001</ArticleId><ArticleId IdType="pii">S2173-5107(24)00137-X</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39603736</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2173-5107</ISSN><JournalIssue CitedMedium="Internet"><Volume>66 Suppl 2</Volume><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Radiologia</Title><ISOAbbreviation>Radiologia (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Future challenges of contrast media in radiology.</ArticleTitle><Pagination><StartPage>S132</StartPage><EndPage>S141</EndPage><MedlinePgn>S132-S141</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rxeng.2024.05.004</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2173-5107(24)00132-0</ELocationID><Abstract><AbstractText>Contrast media (CM) were first used soon after the discovery of X-rays in 1895. Ever since, continuous technological development and pharmaceutical research has led to tremendous progress in radiology, more available techniques and contrast media, and expanded knowledge around their indications. A greater prevalence of chronic diseases, population ageing, and the rise in diagnosis and survival times among cancer patients have resulted in a growing demand for diagnostic imaging and an increased consumption of CM. This article presents the main lines of research in CM development which seek to minimise toxicity and maximise efficacy, opening up new diagnostic and therapeutic possibilities through new molecules or nanomedicine. The sector, which is continuously evolving, faces challenges such as shortages and the need for more equitable and sustainable practices.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 SERAM. Published by Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alvarez-Hornia P&#xe9;rez</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cl&#xed;nica IMQ Zorrotzaurre, Bilbao, Spain; Universidad de Deusto, Bilbao, Spain. Electronic address: edu.alvarezhornia@deusto.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carnelli</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unidad Acad&#xe9;mica de Imagenolog&#xed;a Hospital de Cl&#xed;nicas, Universidad de la Rep&#xfa;blica, Montevideo, Uruguay.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gutierrez</LastName><ForeName>P A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>CH Dunkerque, Department of Radiology, Dunkirk, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez S&#xe1;nchez</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Basurto, Bilbao, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mesa Quesada</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitario Reina Sof&#xed;a, C&#xf3;rdoba, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Radiologia (Engl Ed)</MedlineTA><NlmUniqueID>101770876</NlmUniqueID><ISSNLinking>2173-5107</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="Y">Contrast Media</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005544" MajorTopicYN="Y">Forecasting</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011871" MajorTopicYN="Y">Radiology</DescriptorName><QualifierName UI="Q000639" MajorTopicYN="N">trends</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Computed tomography</Keyword><Keyword MajorTopicYN="N">Contrast media</Keyword><Keyword MajorTopicYN="N">Diagnostic imaging</Keyword><Keyword MajorTopicYN="N">Diagn&#xf3;stico por im&#xe1;genes</Keyword><Keyword MajorTopicYN="N">Ecograf&#xed;a</Keyword><Keyword MajorTopicYN="N">Gadolinio</Keyword><Keyword MajorTopicYN="N">Gadolinium</Keyword><Keyword MajorTopicYN="N">Image enhancement</Keyword><Keyword MajorTopicYN="N">Iodine</Keyword><Keyword MajorTopicYN="N">Magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">Mammography</Keyword><Keyword MajorTopicYN="N">Mamograf&#xed;a</Keyword><Keyword MajorTopicYN="N">Medios de contraste</Keyword><Keyword MajorTopicYN="N">Radiology</Keyword><Keyword MajorTopicYN="N">Radiolog&#xed;a</Keyword><Keyword MajorTopicYN="N">Realce de la imagen</Keyword><Keyword MajorTopicYN="N">Resonancia magn&#xe9;tica</Keyword><Keyword MajorTopicYN="N">Tomograf&#xed;a computarizada</Keyword><Keyword MajorTopicYN="N">Ultrasonography</Keyword><Keyword MajorTopicYN="N">Yodo</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>0</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>20</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39603736</ArticleId><ArticleId IdType="doi">10.1016/j.rxeng.2024.05.004</ArticleId><ArticleId IdType="pii">S2173-5107(24)00132-0</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39603733</PMID><DateCompleted><Year>2024</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2173-5107</ISSN><JournalIssue CitedMedium="Internet"><Volume>66 Suppl 2</Volume><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Radiologia</Title><ISOAbbreviation>Radiologia (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Nursing practice and advanced practice nurses in contrast media safety management.</ArticleTitle><Pagination><StartPage>S110</StartPage><EndPage>S117</EndPage><MedlinePgn>S110-S117</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rxeng.2024.04.002</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2173-5107(24)00112-5</ELocationID><Abstract><AbstractText>In diagnostic imaging departments, there has been a technological evolution in recent years. Progress made in interventional processes and the development of new treatments, as well as an increase in the number of diagnostic and therapeutic tests, has generated a growing and exponential need for specific care. Furthermore, the people who come to these departments are often in a vulnerable state and out of their comfort zone. The implementation of advanced practice nursing (APN) in the context of metabolic therapies and diagnostic imaging provides expert care with a holistic approach to patient care. It uses the nursing care process as a working method which, through research, logical analysis and critical reasoning, enables nursing care to be developed and applied. This approach contributes to safety management in the different processes in which it is engaged. The aim of this article is to highlight the interventions in which nursing practice can contribute to contrast media safety management in a diagnostic imaging department.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024. Published by Elsevier Espa&#xf1;a, S.L.U.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Falip</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Enfermeras de Pr&#xe1;ctica Avanzada, Centro de Diagn&#xf3;stico por Imagen, Hospital Cl&#xed;nic de Barcelona, Barcelona, Spain. Electronic address: sfalip@clinic.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a Arg&#xfc;elles</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Supervisora del &#xc1;rea de Diagn&#xf3;stico y Tratamiento por Imagen del Hospital Universitario Central de Asturias (HUCA), Oviedo, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Crespo</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Enfermeras de Pr&#xe1;ctica Avanzada, Centro de Diagn&#xf3;stico por Imagen, Hospital Cl&#xed;nic de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jurado</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Coordinadora Asistencial de Enfermer&#xed;a, Centro de Diagn&#xf3;stico por Imagen, Hospital Cl&#xed;nic de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oleaga</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>M&#xe9;dico Especialista en Radiodiagn&#xf3;stico, Centro de Diagn&#xf3;stico por la Imagen, Hospital Cl&#xed;nic de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sebasti&#xe0;</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>M&#xe9;dico Especialista en Radiodiagn&#xf3;stico, Centro de Diagn&#xf3;stico por la Imagen, Hospital Cl&#xed;nic de Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Radiologia (Engl Ed)</MedlineTA><NlmUniqueID>101770876</NlmUniqueID><ISSNLinking>2173-5107</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="Y">Contrast Media</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057179" MajorTopicYN="Y">Advanced Practice Nursing</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017751" MajorTopicYN="Y">Safety Management</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D061214" MajorTopicYN="N">Patient Safety</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute kidney injury</Keyword><Keyword MajorTopicYN="N">Advanced practice nursing</Keyword><Keyword MajorTopicYN="N">Adverse drug reaction</Keyword><Keyword MajorTopicYN="N">Contrast media</Keyword><Keyword MajorTopicYN="N">Contrast media extravasation</Keyword><Keyword MajorTopicYN="N">Enfermer&#xed;a de pr&#xe1;ctica avanzada</Keyword><Keyword MajorTopicYN="N">Extravasaci&#xf3;n de medios de contraste</Keyword><Keyword MajorTopicYN="N">Lesi&#xf3;n renal aguda</Keyword><Keyword MajorTopicYN="N">Medios de contraste</Keyword><Keyword MajorTopicYN="N">Nursing process</Keyword><Keyword MajorTopicYN="N">Proceso de enfermer&#xed;a</Keyword><Keyword MajorTopicYN="N">Reacci&#xf3;n adversa a medicamentos</Keyword></KeywordList><CoiStatement>Conflicts of interest The authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>0</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>28</Day><Hour>0</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>27</Day><Hour>20</Hour><Minute>56</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39603733</ArticleId><ArticleId IdType="doi">10.1016/j.rxeng.2024.04.002</ArticleId><ArticleId IdType="pii">S2173-5107(24)00112-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39426811</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2173-5107</ISSN><JournalIssue CitedMedium="Internet"><Volume>66</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>Radiologia</Title><ISOAbbreviation>Radiologia (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Contrast-enhanced mammography and preoperative magnetic seed placement in breast cancer patients for the detection of residual disease following neoadjuvant systemic therapy.</ArticleTitle><Pagination><StartPage>419</StartPage><EndPage>430</EndPage><MedlinePgn>419-430</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rxeng.2024.04.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2173-5107(24)00097-1</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Assess whether contrast-enhanced mammography (CEM) enables an evaluation of the residual size of breast tumours following neoadjuvant systemic therapy (NAST) in patients initially marked with magnetic seed.</AbstractText><AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">This single-centre prospective study was performed between March 2022 and April 2023 with patients with invasive breast carcinoma and lesional marking with magnetic seed. CEM was performed before and after NAST. The lesion size in CEM after NAST was compared to the pathological examination after surgery. Differences between sizes were evaluated and we determined the diagnostic capability indices.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The breast lesions marked with magnetic seed were successfully localised in the preoperative stage for the 42 patients included in the study and selective surgical excision was also achieved in all cases. Tumour diameter after NAST was determined by comparing enhancement on combined CEM images from before and after NAST. The mean diameter was 13.6&#x2009;mm while post-surgical pathological examination determined the mean diameter to be 12.9&#x2009;mm. There were therefore no statistically significant differences between the measurements.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There is a positive correlation and similarity between CEM and pathological examination with regards to the detection of residual disease after NAST, with high specificity and PPV.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 SERAM. Published by Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mariscal Mart&#xed;nez</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Unidad de Diagn&#xf3;stico por la Imagen de la Mama, Servicio de Radiolog&#xed;a, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain. Electronic address: mariscal.germanstrias@gencat.cat.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iglesias Bravo</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Ginecolog&#xed;a, Hospital Virgen de Valme, Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peris Alv&#xe0;</LastName><ForeName>H</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Unidad de Diagn&#xf3;stico por la Imagen de la Mama, Servicio de Radiolog&#xed;a, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rodr&#xed;guez Mart&#xed;nez</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Anatom&#xed;a Patol&#xf3;gica, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luna Tom&#xe1;s</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Ginecolog&#xed;a y Obstetricia, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pascual Miguel</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Servicio de Cirug&#xed;a General, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Puyalto de Pablo</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Servicio de Radiolog&#xed;a, Hospital Universitario Germans Trias i Pujol, Badalona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Radiologia (Engl Ed)</MedlineTA><NlmUniqueID>101770876</NlmUniqueID><ISSNLinking>2173-5107</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="Y">Breast Neoplasms</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020360" MajorTopicYN="Y">Neoadjuvant Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008327" MajorTopicYN="Y">Mammography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018365" MajorTopicYN="Y">Neoplasm, Residual</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="Y">Contrast Media</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011300" MajorTopicYN="N">Preoperative Care</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Breast neoplasms</Keyword><Keyword MajorTopicYN="N">Contrast-enhanced mammography</Keyword><Keyword MajorTopicYN="N">C&#xe1;ncer de mama</Keyword><Keyword MajorTopicYN="N">Magnetic seed</Keyword><Keyword MajorTopicYN="N">Mamograf&#xed;a con contraste</Keyword><Keyword MajorTopicYN="N">Neoadjuvant therapy</Keyword><Keyword MajorTopicYN="N">Semilla magn&#xe9;tica</Keyword><Keyword MajorTopicYN="N">Tratamiento neoadyuvante</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>1</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>20</Day><Hour>4</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>20</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>19</Day><Hour>20</Hour><Minute>54</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39426811</ArticleId><ArticleId IdType="doi">10.1016/j.rxeng.2024.04.001</ArticleId><ArticleId IdType="pii">S2173-5107(24)00097-1</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39122242</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Artificial Intelligence Imaging Diagnosis Using Super-Resolution and Three-Dimensional Shape for Lymph Node Metastasis of Low Rectal Cancer: A Pilot Study From a Single Center.</ArticleTitle><Pagination><StartPage>1131</StartPage><EndPage>1138</EndPage><MedlinePgn>1131-1138</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003381</ELocationID><Abstract><AbstractText Label="BACKGROUND">Although accurate preoperative diagnosis of lymph node metastasis is essential for optimizing treatment strategies for low rectal cancer, the accuracy of present diagnostic modalities has room for improvement.</AbstractText><AbstractText Label="OBJECTIVE">The study aimed to establish a high-precision diagnostic method for lymph node metastasis of low rectal cancer using artificial intelligence.</AbstractText><AbstractText Label="DESIGN">A retrospective observational study.</AbstractText><AbstractText Label="SETTINGS">A single cancer center and a college of engineering in Japan.</AbstractText><AbstractText Label="PATIENTS">Patients with low rectal adenocarcinoma who underwent proctectomy, bilateral lateral pelvic lymph node dissection, and contrast-enhanced multidetector row CT (slice &#x2264;1&#x2009;mm) between July 2015 and August 2021 were included in the present study. All pelvic lymph nodes from the aortic bifurcation to the upper edge of the anal canal were extracted, regardless of whether within or beyond the total mesenteric excision area, and pathological diagnoses were annotated for training and validation.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy.</AbstractText><AbstractText Label="RESULTS">A total of 596 pathologically negative nodes and 43 positive nodes from 52 patients were extracted and annotated. Four diagnostic methods, with and without using super-resolution images and with and without using 3-dimensional shape data, were performed and compared. The super-resolution + 3-dimensional shape data method had the best diagnostic ability for the combination of sensitivity, negative predictive value, and accuracy (0.964, 0.966, and 0.968, respectively), whereas the super-resolution only method had the best diagnostic ability for the combination of specificity and positive predictive value (0.994 and 0.993, respectively).</AbstractText><AbstractText Label="LIMITATIONS">Small number of patients at a single center and the lack of external validation.</AbstractText><AbstractText Label="CONCLUSIONS">Our results enlightened the potential of artificial intelligence for the method to become another game changer in the diagnosis and treatment of low rectal cancer. See Video Abstract .</AbstractText><AbstractText Label="DIAGNSTICO POR IMGENES CON INTELIGENCIA ARTIFICIAL MEDIANTE SUPERRESOLUCIN Y FORMA D PARA LA METSTASIS EN LOS GANGLIOS LINFTICOS DEL CNCER DE RECTO BAJO UN ESTUDIO PILOTO DE UN SOLO CENTRO">ANTECEDENTES:Aunque el diagn&#xf3;stico preoperatorio preciso de met&#xe1;stasis en los ganglios linf&#xe1;ticos es esencial para optimizar las estrategias de tratamiento para el c&#xe1;ncer de recto bajo, la precisi&#xf3;n de las modalidades de diagn&#xf3;stico actuales tiene margen de mejora.OBJETIVO:Establecer un m&#xe9;todo de diagn&#xf3;stico de alta precisi&#xf3;n para las met&#xe1;stasis en los ganglios linf&#xe1;ticos del c&#xe1;ncer de recto bajo utilizando inteligencia artificial.DISE&#xd1;O:Un estudio observacional retrospectivo.AJUSTE:Un &#xfa;nico centro oncol&#xf3;gico y una facultad de ingenier&#xed;a en Jap&#xf3;n.PACIENTES:En el presente estudio se incluyeron pacientes con adenocarcinoma rectal bajo sometidos a proctectom&#xed;a, disecci&#xf3;n bilateral de ganglios linf&#xe1;ticos p&#xe9;lvicos laterales y tomograf&#xed;a computarizada con m&#xfa;ltiples detectores con contraste (corte &#x2264;1&#x2009;mm) entre julio de 2015 y agosto de 2021. Se resecaron todos los ganglios linf&#xe1;ticos p&#xe9;lvicos desde la bifurcaci&#xf3;n a&#xf3;rtica hasta el borde superior del canal anal, independientemente de si estaban dentro o m&#xe1;s all&#xe1; del &#xe1;rea de escisi&#xf3;n mesent&#xe9;rica total, y se registraron los diagn&#xf3;sticos patol&#xf3;gicos para entrenamiento y validaci&#xf3;n.PRINCIPALES MEDIDAS DE RESULTADO:Sensibilidad, especificidad, valor predictivo positivo, valor predictivo negativo y precisi&#xf3;n.RESULTADOS:Se extrajeron y registraron un total de 596 ganglios patol&#xf3;gicamente negativos y 43 positivos de 52 pacientes. Se realizaron y compararon cuatro m&#xe9;todos de diagn&#xf3;stico, con y sin im&#xe1;genes de s&#xfa;per resoluci&#xf3;n y sin datos de imagen en 3D. El m&#xe9;todo de superresoluci&#xf3;n + datos de imagen en 3D tuvo la mejor capacidad de diagn&#xf3;stico para la combinaci&#xf3;n de sensibilidad, valor predictivo negativo y precisi&#xf3;n (0,964, 0,966 y 0,968, respectivamente), mientras que el m&#xe9;todo de s&#xfa;per resoluci&#xf3;n solo tuvo la mejor capacidad de diagn&#xf3;stico para la combinaci&#xf3;n de especificidad y valor predictivo positivo (0,994 y 0,993, respectivamente).LIMITACIONES:Peque&#xf1;o n&#xfa;mero de pacientes en un solo centro y falta de validaci&#xf3;n externa.CONCLUSIONES:Nuestros resultados iluminan el potencial de la inteligencia artificial para que el m&#xe9;todo se convierta en otro elemento de cambio en el diagn&#xf3;stico y tratamiento del c&#xe1;ncer de recto bajo. (Traducci&#xf3;n ---Dr. Fidel Ruiz Healy ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ouchi</LastName><ForeName>Akira</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-0435-5370</Identifier><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iwahori</LastName><ForeName>Yuji</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Computer Science, College of Engineering, Chubu University, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Suzuki</LastName><ForeName>Kosuke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Engineering, Nagoya Institute of Technology, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Funahashi</LastName><ForeName>Kenji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Engineering, Nagoya Institute of Technology, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukui</LastName><ForeName>Shinji</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Information Education, Aichi University of Education, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Komori</LastName><ForeName>Koji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kinoshita</LastName><ForeName>Takashi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sato</LastName><ForeName>Yusuke</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Aichi, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Yasuhiro</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Gastroenterological Surgery, Aichi Cancer Center Hospital, Aichi, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>#20K11873</GrantID><Agency>Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (C)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012004" MajorTopicYN="Y">Rectal Neoplasms</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008207" MajorTopicYN="Y">Lymphatic Metastasis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001185" MajorTopicYN="Y">Artificial Intelligence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008198" MajorTopicYN="Y">Lymph Nodes</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000230" MajorTopicYN="Y">Adenocarcinoma</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000556" MajorTopicYN="N">secondary</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000078542" MajorTopicYN="N">Proctectomy</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D021621" MajorTopicYN="N">Imaging, Three-Dimensional</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061330" MajorTopicYN="N">Multidetector Computed Tomography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010388" MajorTopicYN="N">Pelvis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>10</Day><Hour>15</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>10</Day><Hour>15</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>9</Day><Hour>19</Hour><Minute>39</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39122242</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003381</ArticleId><ArticleId IdType="pii">00003453-202409000-00007</ArticleId></ArticleIdList><ReferenceList><Title/><Reference><Citation>Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery&#x2014;the clue to pelvic recurrence? Br J Surg. 1982;69:613&#x2013;616.</Citation></Reference><Reference><Citation>Cedermark B, Dahlberg M, Glimelius B, P&#xe5;hlman L, Rutqvist LE, Wilking N; Swedish Rectal Cancer Trial. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med. 1997;336:980&#x2013;987.</Citation></Reference><Reference><Citation>Kapiteijn E, Marijnen CA, Nagtegaal ID, et al.; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638&#x2013;646.</Citation></Reference><Reference><Citation>Sauer R, Becker H, Hohenberger W, et al.; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351:1731&#x2013;1740.</Citation></Reference><Reference><Citation>Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811&#x2013;820.</Citation></Reference><Reference><Citation>Cisel B, Pietrzak L, Michalski W, et al.; Polish Colorectal Study Group. Long-course preoperative chemoradiation versus 5&#x2009;&#xd7;&#x2009;5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study. Ann Oncol. 2019;30:1298&#x2013;1303.</Citation></Reference><Reference><Citation>Bahadoer RR, Dijkstra EA, van Etten B, et al.; RAPIDO collaborative investigators. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:29&#x2013;42.</Citation></Reference><Reference><Citation>Conroy T, Bosset JF, Etienne PL, et al.; Unicancer Gastrointestinal Group and Partenariat de Recherche en Oncologie Digestive (PRODIGE) Group. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:702&#x2013;715.</Citation></Reference><Reference><Citation>Jin J, Tang Y, Hu C, et al. Multicenter, randomized, phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol. 2022;40:1681&#x2013;1692.</Citation></Reference><Reference><Citation>Fujita S, Mizusawa J, Kanemitsu Y, et al.; Colorectal Cancer Study Group of Japan Clinical Oncology Group. Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled, noninferiority trial. Ann Surg. 2017;266:201&#x2013;207.</Citation></Reference><Reference><Citation>Hojo K, Koyama Y, Moriya Y. Lymphatic spread and its prognostic value in patients with rectal cancer. Am J Surg. 1982;144:350&#x2013;354.</Citation></Reference><Reference><Citation>Moriya Y, Sugihara K, Akasu T, Fujita S. Nerve-sparing surgery with lateral node dissection for advanced lower rectal cancer. Eur J Cancer. 1995;31:1229&#x2013;1232.</Citation></Reference><Reference><Citation>Sugihara K, Kobayashi H, Kato T, et al. Indication and benefit of pelvic sidewall dissection for rectal cancer. Dis Colon Rectum. 2006;49:1663&#x2013;1672.</Citation></Reference><Reference><Citation>Akiyoshi T, Watanabe T, Miyata S, Kotake K, Muto T, Sugihara K; Japanese Society for Cancer of the Colon and Rectum. Results of a Japanese nationwide multi-institutional study on lateral pelvic lymph node metastasis in low rectal cancer: is it regional or distant disease? Ann Surg. 2012;255:1129&#x2013;1134.</Citation></Reference><Reference><Citation>Emile SH, Horesh N, Freund MR, et al. Trends in the characteristics, treatment, and outcomes of rectal adenocarcinoma in the US from 2004 to 2019: a national cancer database analysis. JAMA Oncol. 2023;9:355&#x2013;364.</Citation></Reference><Reference><Citation>Al-Sukhni E, Milot L, Fruitman M, et al. Diagnostic accuracy of MRI for assessment of T category, lymph node metastases, and circumferential resection margin involvement in patients with rectal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2012;19:2212&#x2013;2223.</Citation></Reference><Reference><Citation>Park JS, Jang YJ, Choi GS, et al. Accuracy of preoperative MRI in predicting pathology stage in rectal cancers: node-for-node matched histopathology validation of MRI features. Dis Colon Rectum. 2014;57:32&#x2013;38.</Citation></Reference><Reference><Citation>Li XT, Sun YS, Tang L, Cao K, Zhang XY. Evaluating local lymph node metastasis with magnetic resonance imaging, endoluminal ultrasound and computed tomography in rectal cancer: a meta-analysis. Colorectal Dis. 2015;17:O129&#x2013;O135.</Citation></Reference><Reference><Citation>Glynne-Jones R, Wyrwicz L, Tiret E, et al.; ESMO Guidelines Committee. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28(suppl 4):iv22&#x2013;iv40.</Citation></Reference><Reference><Citation>Nicholls RJ, Zinicola R, Haboubi N. Extramural spread of rectal cancer and the AJCC Cancer Staging Manual 8th edition, 2017. Ann Oncol. 2019;30:1394&#x2013;1395.</Citation></Reference><Reference><Citation>Benson AB, Venook AP, Al-Hawary MM, et al. NCCN guidelines insights: rectal cancer, version 6.2020. J Natl Compr Canc Netw. 2020;18:806&#x2013;815.</Citation></Reference><Reference><Citation>Zhuang Z, Zhang Y, Wei M, Yang X, Wang Z. Magnetic resonance imaging evaluation of the accuracy of various lymph node staging criteria in rectal cancer: a systematic review and meta-analysis. Front Oncol. 2021;11:709070.</Citation></Reference><Reference><Citation>Lu Y, Yu Q, Gao Y, et al. Identification of metastatic lymph nodes in MR imaging with faster region-based convolutional neural networks. Cancer Res. 2018;78:5135&#x2013;5143.</Citation></Reference><Reference><Citation>Jin L, Peng W, Yanzhao L, Yang Z, Xiaolong L, Kuan L. Transfer learning of pre- trained inception-v3 model for colorectal cancer lymph node metastasis classification. In: 2018 IEEE International Conference on Mechatronics and Automation (ICMA); August 1, 2018; Changchun, China.</Citation></Reference><Reference><Citation>Ozaki K, Kurose Y, Kawai K, et al. Development of a diagnostic artificial intelligence tool for lateral lymph node metastasis in advanced rectal cancer. Dis Colon Rectum. 2023;66:e1246&#x2013;e1253.</Citation></Reference><Reference><Citation>Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012;30:1323&#x2013;1341.</Citation></Reference><Reference><Citation>Heijnen LA, Lambregts DM, Mondal D, et al. Diffusion-weighted MR imaging in primary rectal cancer staging demonstrates but does not characterise lymph nodes. Eur Radiol. 2013;23:3354&#x2013;3360.</Citation></Reference><Reference><Citation>Yu J, Dai X, Zou HH, et al. Diffusion kurtosis imaging in identifying the malignancy of lymph nodes during the primary staging of rectal cancer. Colorectal Dis. 2018;20:116&#x2013;125.</Citation></Reference><Reference><Citation>Yu XP, Wen L, Hou J, Wang H, Lu Q. Discrimination of metastatic from non-metastatic mesorectal lymph nodes in rectal cancer using quantitative dynamic contrast-enhanced magnetic resonance imaging. J Huazhong Univ Sci Technolog Med Sci. 2016;36:594&#x2013;600.</Citation></Reference><Reference><Citation>Nakao T, Shimada M, Yoshikawa K, et al. Computed tomography texture analysis for the prediction of lateral pelvic lymph node metastasis of rectal cancer. World J Surg Oncol. 2022;20:281.</Citation></Reference><Reference><Citation>Sato K, Morohashi H, Tsushima F, et al. Dual energy CT is useful for the prediction of mesenteric and lateral pelvic lymph node metastasis in rectal cancer. Mol Clin Oncol. 2019;10:625&#x2013;630.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39087688</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>21</Day></DateCompleted><DateRevised><Year>2025</Year><Month>07</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Comparative Study of Diluted Hydrogen Peroxide and Sulfur Hexafluoride in the Contrast-Enhanced Ultrasound Assessment of Anal Fistulas.</ArticleTitle><Pagination><StartPage>1450</StartPage><EndPage>1457</EndPage><MedlinePgn>1450-1457</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003445</ELocationID><Abstract><AbstractText Label="BACKGROUND">Endoanal ultrasound for the diagnosis of anal fistulas requires the injection of hydrogen peroxide, but it is often uncomfortable for the patient and has the potential to cause complications. Novel ultrasound contrast is currently available.</AbstractText><AbstractText Label="OBJECTIVE">To assess the efficacy and safety of sulfur hexafluoride as an ultrasound contrast agent for the diagnosis of a perianal fistula by comparing it with those of 50% diluted hydrogen peroxide.</AbstractText><AbstractText Label="DESIGN">Double-blinded superiority study with 4 consecutive visits to perform an ultrasound without contrast, a hydrogen peroxide-enhanced ultrasound, a sulfur hexafluoride-enhanced ultrasound, and a rectal exploration in the operating room (the criterion standard). The 3 expert surgeon sonographers independently reviewed the ultrasound images.</AbstractText><AbstractText Label="SETTING">This study was conducted at a single university hospital.</AbstractText><AbstractText Label="PATIENTS">Data from 176 patients were evaluated.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES">Demographic and exploratory data and the ultrasound findings related to the location of the internal fistula orifice, description of the primary and secondary tracts, and presence of cavities and sphincter defects were analyzed. Complications occurring before and after the contrast agent administration and pain score measured using a visual analog scale were considered.</AbstractText><AbstractText Label="RESULTS">Eighty-eight patients were included (men: 71.5%; mean age: 48.3 years), with 62.5% having a complex type fistula and 83.7% having a transsphincteric type fistula. Sulfur hexafluoride-enhanced ultrasounds demonstrated a higher interobserver agreement in determining the secondary tracts (&#x3ba; = 0.604) and anal fistula height (&#x3ba; = 0.604) compared with other methods. Both hydrogen peroxide-enhanced ultrasound (90.91%) and sulfur hexafluoride-enhanced ultrasound (89.77%) detected the internal orifice more frequently than ultrasounds without contrast (62.5%; p &lt; 0.001), with no differences between contrast agents ( p = 0.810). Sulfur hexafluoride-enhanced ultrasound was less painful than peroxide-enhanced ultrasound ( p &lt; 0.001).</AbstractText><AbstractText Label="LIMITATIONS">Most of the patients had transsphincteric anal fistulas.</AbstractText><AbstractText Label="CONCLUSIONS">Sulfur hexafluoride proved comparable to hydrogen peroxide in evaluating fistulous tracts and identifying the internal orifice, and it significantly reduced pain and discomfort. Furthermore, it demonstrated a higher interobserver agreement in determining the secondary tracts and anal fistula height compared with other methods. See Video Abstract .</AbstractText><AbstractText Label="ESTUDIO COMPARATIVO DE PERXIDO DE HIDRGENO DILUIDO Y HEXAFLUORURO DE AZUFRE EN LA EVALUACIN ECOGRFICA CON CONTRASTE DE FSTULAS ANALES">ANTECEDENTES:La ecograf&#xed;a endoanal para el diagn&#xf3;stico de f&#xed;stulas anales requiere la inyecci&#xf3;n de per&#xf3;xido de hidr&#xf3;geno, pero generalmente resulta inc&#xf3;moda para el paciente y presenta potenciales complicaciones. Actualmente se encuentran disponibles nuevos contrastes ecogr&#xe1;ficos.OBJETIVO:Evaluar la eficacia y seguridad del hexafluoruro de azufre como agente de contraste ecogr&#xe1;fico para el diagn&#xf3;stico de f&#xed;stula perianal compar&#xe1;ndolo con el per&#xf3;xido de hidr&#xf3;geno diluido al 50%.DISE&#xd1;O:Estudio de superioridad doble ciego con cuatro visitas consecutivas realizando una ecograf&#xed;a sin contraste, ecograf&#xed;a potenciada con per&#xf3;xido de hidr&#xf3;geno, ecograf&#xed;a potenciada con hexafluoruro de azufre y exploraci&#xf3;n rectal en el quir&#xf3;fano (el est&#xe1;ndar de oro). Las im&#xe1;genes ecogr&#xe1;ficas fueron revisadas de forma independiente por tres cirujanos ecografistas expertos.AJUSTE:Estudio llevado a cabo en un &#xfa;nico hospital universitario.PACIENTES:Se evaluaron datos de 176 pacientes.PRINCIPALES MEDIDAS DE RESULTADO:Se analizaron los datos demogr&#xe1;ficos y exploratorios y los hallazgos ecogr&#xe1;ficos relacionados con la ubicaci&#xf3;n del orificio interno de la f&#xed;stula, descripci&#xf3;n de los trayectos primario y secundario y la presencia de cavidades y defectos del esf&#xed;nter. Se consideraron las complicaciones ocurridas antes y despu&#xe9;s de la administraci&#xf3;n del agente de contraste y la presencia de dolor medido mediante un puntaje.RESULTADOS:Se incluyeron 88 pacientes (hombres: 71,5%; edad media: 48,3 a&#xf1;os). El 62,5% fueron tipo complejo y el 83,7% tipo transesfint&#xe9;rico. Las ecograf&#xed;as mejoradas con hexafluoruro de azufre demostraron mayor concordancia interobservador en la determinaci&#xf3;n de los trayectos secundarios (&#x3ba; = 0,604) y la altura de la f&#xed;stula anal (&#x3ba; = 0,604) en comparaci&#xf3;n con otros m&#xe9;todos. Tanto la ecograf&#xed;a con per&#xf3;xido de hidr&#xf3;geno (90,91%) como la ecograf&#xed;a con hexafluoruro de azufre (89,77%) detectaron con mayor frecuencia el orificio interno que la ecograf&#xed;a sin contraste (62,5%) (p &lt; 0,001), sin diferencias entre agentes de contraste (p = 0,810). La ecograf&#xed;a potenciada con hexafluoruro de azufre fue menos dolorosa que la ecograf&#xed;a potenciada con per&#xf3;xido (p &lt; 0,001).LIMITACIONES:La mayor&#xed;a de los pacientes presentaron f&#xed;stulas anales transesfint&#xe9;ricas.CONCLUSIONES:El hexafluoruro de azufre demostr&#xf3; ser comparable al per&#xf3;xido de hidr&#xf3;geno en la evaluaci&#xf3;n de los trayectos fistulosos y la identificaci&#xf3;n del orificio interno y con reducci&#xf3;n significativa del dolor y malestar. Adem&#xe1;s, demostr&#xf3; mayor concordancia interobservador en la determinaci&#xf3;n de los trayectos secundarios y la altura de la f&#xed;stula anal en comparaci&#xf3;n con otros m&#xe9;todos. (Traducci&#xf3;n-Dr. Fidel Ruiz Healy ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de la Portilla de Juan</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Colorectal Unit, Department of General and Digestive Surgery, University Hospital Virgen del Roc&#xed;o, Seville University. Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Le&#xf3;n</LastName><ForeName>Anabel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General and Digestive Surgery, University Hospital Virgen del Roc&#xed;o, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-S&#xe1;nchez</LastName><ForeName>Carlos Javier</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of General and Digestive Surgery, University Hospital Virgen del Roc&#xed;o, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mar&#xed;n</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of General and Digestive Surgery, Colorectal Unit, University Hospital Virgen del Roc&#xed;o, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reyes-D&#xed;az</LastName><ForeName>Mar&#xed;a L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of General and Digestive Surgery, Colorectal Unit, University Hospital Virgen del Roc&#xed;o, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>V&#xe1;zquez-Monchul</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General and Digestive Surgery, Colorectal Unit, University Hospital Virgen del Roc&#xed;o, Seville, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Padillo Ruiz</LastName><ForeName>Francisco J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Department of General and Digestive Surgery, University Hospital Virgen del Roc&#xed;o, Seville University. Seville, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D003287">Contrast Media</NameOfSubstance></Chemical><Chemical><RegistryNumber>WS7LR3I1D6</RegistryNumber><NameOfSubstance UI="D013459">Sulfur Hexafluoride</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012003" MajorTopicYN="Y">Rectal Fistula</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003287" MajorTopicYN="Y">Contrast Media</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013459" MajorTopicYN="Y">Sulfur Hexafluoride</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006861" MajorTopicYN="Y">Hydrogen Peroxide</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004311" MajorTopicYN="N">Double-Blind Method</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019160" MajorTopicYN="N">Endosonography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014463" MajorTopicYN="N">Ultrasonography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001003" MajorTopicYN="N">Anal Canal</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>22</Day><Hour>4</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>1</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>1</Day><Hour>8</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39087688</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003445</ArticleId><ArticleId IdType="pii">00003453-202411000-00013</ArticleId></ArticleIdList><ReferenceList><Title/><Reference><Citation>Parks AG, Gordon PH, Hardcastle JE. A classification of fistula-in-ano. Br J Surg. 1976;63:1&#x2013;12.</Citation></Reference><Reference><Citation>Schwartz DA, Wiersema MJ, Dudiak KM, et al. A comparison of endoscopic ultrasound, magnetic resonance imaging, and exam under anesthesia for evaluation of Crohn&#x2019;s perianal fistulas. Gastroenterology. 2001;121:1064&#x2013;1072.</Citation></Reference><Reference><Citation>De la Portilla F, Al&#xf3;s R, Solana A, et al. Usefulness of anorectal ultrasounds in perianal Crohn&#x2019;s disease. Cir Esp. 2001;69:459&#x2013;462.</Citation></Reference><Reference><Citation>Sloots CE, Felt-Bersma RJ, Poen AC, Cuesta MA, Meuwissen SG. Assessment and classification of fistula-in-ano in patients with Crohn&#x2019;s disease by hydrogen peroxide enhanced transanal ultrasound. Int J Colorectal Dis. 2001;16:292&#x2013;297.</Citation></Reference><Reference><Citation>Van Bodegraven AA, Sloots CE, Felt-Bersma RJ, et al. Endosonographic evidence of persistence of Crohn&#x2019;s disease-associated fistulas after infliximab treatment, irrespective of clinical response. Dis Colon Rectum. 2001;45:39&#x2013;45.</Citation></Reference><Reference><Citation>De la Portilla F, Le&#xf3;n-Jim&#xe9;nez E, Cisneros N, et al. Use of anorectal ultrasounds in perianal Crohn&#x2019;s disease: consistency with clinical data. Rev Esp Enferm Dig. 2006;98:747&#x2013;754.</Citation></Reference><Reference><Citation>Siddiqui MRS, Ashrafian H, Tozer P, et al. A diagnostic accuracy meta-analysis of endoanal ultrasound and MRI for perianal fistula assessment. Dis Colon Rectum. 2012;55:576&#x2013;585.</Citation></Reference><Reference><Citation>Choen S, Burnett S, Bartram CI, Nicholls RJ. Comparison between anal endosonography and digital examination in the evaluation of anal fistulae. Br J Surg. 1991;78:445&#x2013;447.</Citation></Reference><Reference><Citation>Kim Y, Jin Park Y. Three-dimensional endoanal ultrasonographic assessment of an anal fistula with and without H 2 O 2 enhancement. World J Gastroenterol. 2009;15:4810&#x2013;4815.</Citation></Reference><Reference><Citation>Tsai SK, Lee TY, Mok MS. Gas embolism produced by hydrogen peroxide irrigation of an anal fistula during anesthesia. Anesthesiology. 1985;63:316&#x2013;317.</Citation></Reference><Reference><Citation>Kiran S, Marwah S, Bansal T, Gupta N. Venous air/oxygen embolism due to hydrogen peroxide in anal fistulectomy. J Anaesthesiol Clin Pharmacol. 2018;34:555&#x2013;557.</Citation></Reference><Reference><Citation>Schwab C, Dilworth K. Gas embolism produced by hydrogen peroxide abscess irrigation in an infant. Anaesth Intensive Care. 1999;27:418&#x2013;420.</Citation></Reference><Reference><Citation>Jones PM, Segal SH, Gelb AW. Venous oxygen embolism produced by injection of hydrogen peroxide into an enterocutaneous fistula. Anesth Analg. 2004;99:1861&#x2013;1863.</Citation></Reference><Reference><Citation>Cina SJ, Downs JC, Conradi SE. Hydrogen peroxide: a source of lethal oxygen embolism. Case report and review of the literature. Am J Forensic Med Pathol. 1994;15:44&#x2013;50.</Citation></Reference><Reference><Citation>Despond O, Fiset P. Oxygen venous embolism after the use of hydrogen peroxide during lumbar discectomy. Can J Anaesth. 1997;44:410&#x2013;413.</Citation></Reference><Reference><Citation>Dubey PK, Singh AK. Venous oxygen embolism due to hydrogen peroxide irrigation during posterior fossa surgery. J Neurosurg Anesthesiol. 2000;12:54&#x2013;56.</Citation></Reference><Reference><Citation>Chua ME, Kim JK, Mendoza JS, et al. The evaluation of vesicoureteral reflux among children using contrast-enhanced ultrasound: a literature review. J Pediatr Urol. 2019;15:12&#x2013;17.</Citation></Reference><Reference><Citation>He Y, Wu H, Xiong R, et al. Intravasation affects the diagnostic image quality of transvaginal 4-dimensional hysterosalpingo-contrast sonography with SonoVue. J Ultrasound Med. 2019;38:2169&#x2013;2180.</Citation></Reference><Reference><Citation>Lu Y, Liu B, Zheng Y, et al. Application of real-time three-dimensional contrast-enhanced ultrasound using SonoVue for the evaluation of focal liver lesions: a prospective single-center study. Am J Transl Res. 2018;10:1469&#x2013;1480.</Citation></Reference><Reference><Citation>Chew SS, Yang JL, Newstead GL, Douglas PR. Anal fistula: Levovist-enhanced endoanal ultrasound: a pilot study. Dis Colon Rectum. 2003;46:377&#x2013;384.</Citation></Reference><Reference><Citation>Shang Y, Xie X, Luo Y, et al. Safety findings after intravenous administration of sulfur hexafluoride microbubbles to 463,434 examinations at 24 centers. Eur Radiol. 2023;33:988&#x2013;995.</Citation></Reference><Reference><Citation>Poen AC, Felt-Bersma RJ, Eijsbouts QA, Cuesta MA, Meuwissen SG. Hydrogen peroxide-enhanced transanal ultrasound in the assessment of fistula-in-ano. Dis Colon Rectum. 1998;41:1147&#x2013;1152.</Citation></Reference><Reference><Citation>Navarro-Luna A, Garcia-Domingo MI, Rius-Macias J, Marco-Molina C. Ultrasound study of anal fistulas with hydrogen peroxide enhancement. Dis Colon Rectum. 2004;47:108&#x2013;114.</Citation></Reference><Reference><Citation>West RL, Zimmerman DD, Dwarkasing S, et al. Prospective comparison of hydrogen peroxide-enhanced three-dimensional endoanal ultrasonography and endoanal magnetic resonance imaging of perianal fistulas. Dis Colon Rectum. 2003;46:1407&#x2013;1415.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>